FARMACIA Y SALUD
Doktorego eskola
Hospital General de Castellón
Castelló de la Plana, EspañaHospital General de Castellón-ko ikertzaileekin lankidetzan egindako argitalpenak (8)
2024
-
Comparative Study of the Effectiveness of Vedolizumab Versus Ustekinumab After Anti-TNF Failure in Crohn's Disease (Versus-CD): Data from the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 18, Núm. 1, pp. 65-74
2023
-
Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
Journal of Crohn's & colitis, Vol. 17, Núm. 1, pp. 83-91
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2008
-
Recomendaciones para la monitorización de antibióticos en pacientes críticos ingresados en UCI
Enfermedades Infecciosas y Microbiologia Clinica
-
Recommendations for antibiotic monitoring in ICU patients
Farmacia Hospitalaria
2007
-
A bibliometric analysis of the Farmacia Hospitalaria journal (2001-2006)
Farmacia Hospitalaria
2005
-
Sublingual immunotherapy for hazelnut food allergy: A randomized, double-blind, placebo-controlled study with a standardized hazelnut extract
Journal of Allergy and Clinical Immunology, Vol. 116, Núm. 5, pp. 1073-1079